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FAST TRACK
Experts 
recommend a 
repeat morning 
testosterone level, 
plus testing levels 
of FSH, LH, and 
prolactin to 
evaluate the cause 
of low testosterone
  
Obtain a repeat morning testosterone 
level, as well as levels of follicle-stimulating 
hormone (FSH), luteinizing hormone (LH), 
and prolactin to help understand the cause 
of low testosterone when there is a lack 
of adequate empiric evidence to guide 
evaluation, advise the experts. When low 
or normal FSH and LH levels accompany 
low testosterone, evaluation of the pituitary 
gland is recommended. 
 Chromosomal studies are indicated 
in prepubertal males with low testosterone 
and elevated FSH and LH levels to 
assess for Klinefelter syndrome. Perform 
a semen analysis if fertility is an issue. 
Bone densitometry is indicated in men 
with chronic hypogonadism to identify 
increased risk of hip fracture (strength of all 
recommendations: C, consensus guidelines 
and disease-oriented evidence).
Evidence-based answer
Clinical commentary
Diagnosis is often straightforward, 
but treatment … not so much
The causes of low testosterone are diverse 
and vary across the life span (TABLE).1,2 
Although screening tests are integral to 
the evaluation, a successful diagnostic 
approach must begin with a detailed history 
and physical exam. Clinical clues coupled 
with judiciously selected tests typically lead 
to a straightforward diagnosis. 
 The decision whether or not to 
treat a patient diagnosed with partial 
androgen defi ciency of aging is often less 
clear, especially when clinical symptoms 
are minimal or absent. The benefi ts of 
testosterone replacement therapy are 
signifi cant, but so are the potential risks. 
Shared decision making with the patient is 
key to this dilemma.
Pamela A. Williams, MD
Uniformed Services University 
of the Health Sciences, Bethesda, Md
❚ Evidence summary
Our search retrieved no randomized 
controlled clinical trials evaluating the 
screening tests required to work-up a 
male with low testosterone. We there-
fore examined 2 consensus guidelines, 9 
review articles, and disease-oriented evi-
dence. The recommendations discussed 
here are based primarily on consensus 
guidelines and disease-oriented evidence.
Hypogonadism increases with age
Hypogonadism is a common endocri-
nologic disorder in men. Advancing age, 
increased life expectancy, and a rising 
prevalence of obesity and type 2 diabetes 
may increase the occurrence of hypogo-
nadism.3 Many cases result from partial 
What screening tests should 
you use to evaluate a man 
with low testosterone?
Robert P. Jackman, MD
Cascades East Family Medicine 
Residency, Oregon Health and 
Science University, Klamath 
Falls, Ore
Dolores Zegar Judkins, MLS
Oregon Health and Science 
University, Portland, Ore
756_JFP1108   756 10/17/08   1:28:32 PM
C py
right
® Dow
den H
ealth
 Med
i   
For p
er on
al us
e onl
y
For mass reproduction, content licensing and permissions contact Dowden Health Media.
FAST TRACK
 VOL 57, NO 11 / NOVEMBER 2008 757www.jfponline.com
androgen defi ciency in the aging male, 
because testosterone levels decline an esti-
mated 1% to 2% per year in adult men.1,3 
A focused, cost-effective work-up will 
become ever more critical because an es-
timated 19% of men will be 65 years or 
older by 2050.4
Serum testosterone: 
The ﬁ rst-choice test
Serum testosterone measurements are 
considered the initial test of choice be-
cause they’re reliable, inexpensive, and 
widely available. Testosterone levels vary 
from hour to hour and diurnally, so a 
repeat morning measurement is recom-
mended to confi rm subnormal levels.3,5 
In some cases—including patients 
with obesity, type 2 diabetes, or hypothy-
roidism—the total testosterone level can 
be misleading; tests for free testosterone 
and sex hormone-binding globulin levels 
should be ordered. These tests can also 
help evaluate men with low-normal total 
testosterone levels (200-400 ng/dL).6,7
Is the patient pre- or postpubertal?
Assessment of low testosterone should 
distinguish between pre- and postpu-
bertal males. In prepubertal males, 
chromosomal analysis is indicated be-
cause hypothalamic-pituitary-gonadal 
axis defects are common—especially 
Klinefelter syndrome (1 in 500 males).6,8 
Men with very low testosterone levels 
(<150 ng/dL) or signs and symptoms 
suggesting pituitary pathology warrant 
pituitary imaging and measurement of 
thyroxine, cortisol, and prolactin lev-
els.6 Both pre- and postpubertal males 
Prepubertal males 
with low 
testosterone and 
elevated FSH and 
LH should undergo 
chromosomal 
studies to assess for 
Klinefelter syndrome
Causes of hypogonadism 
CLASS LOCATION CAUSES
Primary 
(low testosterone, 
elevated FSH)
Testes Congenital
Biosynthesis and chromosomal disorders (rare)
Klinefelter syndrome (most common, 
    1:500-1000 males)
Acquired
Chemotherapeutic agents
Autoimmune disorders
Aging
Drugs
Toxins (eg, alcohol)
Infection
Trauma
Radiation
Idiopathic causes
Secondary
(low testosterone, 
normal or low FSH)
Pituitary gland Congenital
Kallmann syndrome (1:10,000 male births)
Idiopathic causes
Abnormal structural hormone defects
Acquired
Chronic disease
Drugs (eg, chronic opioids)
Infection (eg, HIV)
Trauma
Tumors
Idiopathic causes
Age-related 
(low testosterone, 
normal or elevated FSH)
Testes/hypothalamus Aging (common; 1%-2% per year after 65 years 
of age, 30%-70% at 60-80 years of age)
FSH, follicle-stimulating hormone; HIV, human immunodefi ciency virus.
Sources: Darby E et al1 and Badar F et al.2
TABLE
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with low testosterone should have FSH, 
LH, and prolactin levels tested to dif-
ferentiate primary from secondary hy-
pogonadism.6,9 
Be alert for hemochromatosis 
and low bone density
Order biopsy or ultrasound examination 
of testicular masses and iron studies if 
hemochromatosis is suspected. Hemo-
chromatosis is the most common single 
gene disorder of Caucasian Americans (1 
in 250-300 are homozygous; 1 in 10 are 
heterozygous) and is associated with hy-
pogonadotrophic hypogonadism.5,10 In a 
series of 3 studies, 30% (26 of 89) of men 
with hemochromatosis had hypogonad-
ism.11 The prevalence of hemochroma-
tosis in males with hypogonadism hasn’t 
been reported.
Because chronic hypogonadism leads 
to low bone density and increased risk 
of fracture, baseline bone densitometry 
may be prudent.12 A chart review study 
of nursing home residents found that 
66% of men with hip fractures and 20% 
of men with vertebral fractures had low 
testosterone.13 Notably, 50% of men in 
their 80s have testosterone levels in the 
hypogonadal range (<300 ng/dL), com-
pared with 12% of men <50 years.1,14
Recommendations
Scant guidance is available concerning 
what screening tests to order for a male 
with low testosterone. The United States 
Preventive Services Task Force and Ca-
nadian Task Force on Preventive Health 
Care make no recommendations; the Co-
chrane collaboration has no reviews on 
the topic. The American Association of 
Clinical Endocrinologists’ (AACE) guide-
lines are based on expert opinion.3 
The AACE consensus guideline used 
peer review for validation and didn’t spec-
ify the method used to assess the quality 
and strength of the evidence used to write 
the statement. The AACE guideline recom-
mends a history and physical exam, ob-
taining repeat morning testosterone levels, 
prolactin, FSH, LH, bone densitometry, 
and a semen analysis if fertility is an issue. 
In acquired hypogonadism, pituitary 
imaging is recommended along with thy-
roid, adrenal, and growth hormone axis 
testing. Prepubertal males should under-
go chromosome analysis, and men with 
a suspected mass should have a testicular 
ultrasound examination. ■
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Consider checking 
for osteoporosis in 
men with chronic 
hypogonadism
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